Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
$36.93 - $74.50
Next Earnings Date
May 08 2025
Next Earnings Date
May 08 2025
Latest price
Market Cap | $3.31B |
EV | $3.05B |
Shares Outstanding | 51.78M |
Beta | -2.29 |
Analyst Rating | BUY |
Analyst Target Price | $108.63 |
P/E 2025E | - |
P/Revenue 2025E | 83.33x |
Revenue | - |
EPS | 9.20% |
Operating Cash Flow | -35.50% |
Free Cash Flow | 22.60% |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | 90.00% |
Net Profit Margin 2025E | -371.30% |
ROE 2025E | - |
ROCE 2024 | -87.35% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Soleno Therapeutics, Inc.
SLNO
Sector
Healthcare
Industry
Biotechnology
CEO
Bhatnagar, Anish
Employees
92
Website
soleno.lifeIPO Date
2014-11-13
Headquarters
203 Redwood Shores Parkway, Suite 500, Redwood City, California, 94065, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved